These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 38487948)
1. Potential biomarkers in breast cancer drug development: application of the biomarker qualification evidentiary framework. Wang E; Henderson M; Yalamanchili P; Cueto J; Islam Z; Dharmani C; Salas M Biomark Med; 2024; 18(6):265-277. PubMed ID: 38487948 [TBL] [Abstract][Full Text] [Related]
2. Biomarkers for the clinical management of breast cancer: international perspective. Patani N; Martin LA; Dowsett M Int J Cancer; 2013 Jul; 133(1):1-13. PubMed ID: 23280579 [TBL] [Abstract][Full Text] [Related]
3. BRCA1, a potential predictive biomarker in the treatment of breast cancer. James CR; Quinn JE; Mullan PB; Johnston PG; Harkin DP Oncologist; 2007 Feb; 12(2):142-50. PubMed ID: 17296808 [TBL] [Abstract][Full Text] [Related]
4. Ki-67 index as a prognostic factor of subsequent lapatinib-based therapy in HER2-positive metastatic breast cancer with resistance to trastuzumab. Bian L; Wang T; Zhang SH; Zhang HQ; Guo YF; Du G; Li W; Wu SK; Song ST; Jiang ZF Cancer Biol Ther; 2014 Apr; 15(4):365-70. PubMed ID: 24424115 [TBL] [Abstract][Full Text] [Related]
6. (Very) Early technology assessment and translation of predictive biomarkers in breast cancer. Miquel-Cases A; Schouten PC; Steuten LM; Retèl VP; Linn SC; van Harten WH Cancer Treat Rev; 2017 Jan; 52():117-127. PubMed ID: 27992844 [TBL] [Abstract][Full Text] [Related]
8. Industry perspectives on biomarker qualification. Lavezzari G; Womack AW Clin Pharmacol Ther; 2016 Feb; 99(2):208-13. PubMed ID: 26378777 [TBL] [Abstract][Full Text] [Related]
9. Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline. Harris LN; Ismaila N; McShane LM; Andre F; Collyar DE; Gonzalez-Angulo AM; Hammond EH; Kuderer NM; Liu MC; Mennel RG; Van Poznak C; Bast RC; Hayes DF; J Clin Oncol; 2016 Apr; 34(10):1134-50. PubMed ID: 26858339 [TBL] [Abstract][Full Text] [Related]
10. Breast cancer: Biology, biomarkers, and treatments. Barzaman K; Karami J; Zarei Z; Hosseinzadeh A; Kazemi MH; Moradi-Kalbolandi S; Safari E; Farahmand L Int Immunopharmacol; 2020 Jul; 84():106535. PubMed ID: 32361569 [TBL] [Abstract][Full Text] [Related]
11. Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer. Perez EA; de Haas SL; Eiermann W; Barrios CH; Toi M; Im YH; Conte PF; Martin M; Pienkowski T; Pivot XB; Burris HA; Stanzel S; Patre M; Ellis PA BMC Cancer; 2019 May; 19(1):517. PubMed ID: 31146717 [TBL] [Abstract][Full Text] [Related]
12. Biomarker development in the context of urologic cancers. Kelloff GJ; Sigman CC; Scher HI Urol Oncol; 2015 Jun; 33(6):295-301. PubMed ID: 25746942 [TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis. Ward S; Scope A; Rafia R; Pandor A; Harnan S; Evans P; Wyld L Health Technol Assess; 2013 Oct; 17(44):1-302. PubMed ID: 24088296 [TBL] [Abstract][Full Text] [Related]
14. CCNA2 is a prognostic biomarker for ER+ breast cancer and tamoxifen resistance. Gao T; Han Y; Yu L; Ao S; Li Z; Ji J PLoS One; 2014; 9(3):e91771. PubMed ID: 24622579 [TBL] [Abstract][Full Text] [Related]
15. Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat? Toss A; Venturelli M; Peterle C; Piacentini F; Cascinu S; Cortesi L Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28054957 [TBL] [Abstract][Full Text] [Related]
20. uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies. Duffy MJ; McGowan PM; Harbeck N; Thomssen C; Schmitt M Breast Cancer Res; 2014 Aug; 16(4):428. PubMed ID: 25677449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]